4. In the March 2019 quarterly financial statements, there does not appear to be any revenue received from Mabsut Life despite the announcement in November 2017 stating 'Under the agreement MXC will supply a specialised CBD extract to Mabsut Life at a minimum of 12kg of CBD extract per quarter'. Can MGC explain why there does not appear to be any revenue received from Mabsut Life in this March 2019 quarter?
Ann: Brazil Distribution Agreement signed for MGC Pharma Products, page-52
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $15.97M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 36.5¢ | 32.5¢ | $8.486K | 24.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 3333 | 1 |
View Market Depth
| Last trade - 15.46pm 03/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |